Immunogobulin conjugates
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 25, 1998
Issued Date -
N/A
app pub date -
Apr 11, 1995
filing date -
Mar 11, 1987
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Immunoglobulin conjugates, comprising idarubicin (Ida) conjugated to a monoclonal antibody or fragment thereof comprising at least one of the antigen binding sites of the antigen, are useful for treating a human or other animal suffering from a cancer or for depleting a subset of T lymphocytes from a population of cells.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully